Military Smallpox Vaccine
Program Deemed Safe
Side effects from 450,000 vaccinations were lower
than expected, researchers conclude.
By Kathleen Doheny
HealthDay Reporter
TUESDAY, June 24 (HealthDayNews) -- The large-scale
smallpox vaccination of U.S. military personnel launched
last December proved to be safe with relatively few side
effects, according to new research.
For the study, funded by the military, researchers
evaluated the vaccinations of 450,293 military personnel
after their immunization and found that fewer suffered
from adverse events than had been predicted, says Col.
John Grabenstein, deputy director for military vaccines
at the Army Surgeon General's Office in Falls Church,
Va. Grabenstein is a co-author of the study, published
in the June 25 Journal of the American Medical
Association.
Short-term sick leave was requested by few military
personnel, he says. At the Walter Reed Army Medical
Center in Washington, D.C., for instance, 16 of 530
people, or 3 percent of those vaccinated there, took
sick leave of usually one day about 8 to 12 days after
the immunizations. Other sites had similar time-off
requests, he adds.
Grabenstein says some experts had predicted that
one-third of those vaccinated would need a week off
after the vaccines.
One case of encephalitis (brain inflammation) and 37
cases of myopericarditis (heart inflammation) occurred,
he says. No deaths were attributed to the vaccine use.
The decision to start large-scale vaccination came in
response to fears of a bioterrorist attack using
smallpox virus.
"This is a vaccine that needs to be used very
carefully, and so we did," Grabenstein says.
"We saw inflammation of the heart a bit more
frequently [than we expected]," he says, adding,
however, that the 37 cases still are a relatively low
number compared with the number of vaccinations given.
Those affected were hospitalized and monitored, he adds.
Careful training of the vaccine recipients was one
reason that adverse events were low, Grabenstein notes.
People were instructed to wear a bandage over the
injection site for two to three weeks and to wear long
sleeves over the bandage. "The virus [from the vaccine]
sits on the surface of the skin," Grabenstein says.
Scratching the site, then, can spread the virus.
The vaccine used was a live virus called "vaccinia
virus," a virus related to smallpox that helps the body
develop immunity, according to the federal Centers for
Disease Control and Prevention. The vaccine does not
contain the smallpox virus, however, the CDC emphasizes,
and cannot cause smallpox.
Smallpox is highly contagious, spreads from person to
person and can be fatal. Fever and a skin rash are two
common symptoms. The rash spreads and progresses to
raised bumps and blisters filled with pus. These crust,
scab and fall off after three weeks or so, scarring the
skin.
The last case of smallpox reported in the United
States was in 1949, according to the CDC, and the last
known case in the world that occurred naturally was in
1977 in Somalia.
Even with the possibility that terrorists could
unleash the smallpox virus in a biological attack, the
CDC advises that certain people should not be
vaccinated, including anyone with atopic dermatitis or
other skin conditions such as psoriasis or severe acne
as well as anyone with a weakened immune system.
Pregnant women should not be vaccinated and were
exempted from the military vaccinations, Grabenstein
says, as was anyone with the skin conditions cited.
Even so, 85 military women were vaccinated before
they discovered they were pregnant and are now being
followed closely in a special registry.
Another report in the same journal concludes that
people who were vaccinated previously could be
vaccinated again with diluted vaccine. According to the
CDC, the vaccine offers protection for 3 to 5 years,
with decreasing immunity thereafter.
More information
To learn more about smallpox, check out information
from the
Centers for Disease Control and Prevention or the
World Health Organization.
Copyright © 2003 ScoutNews, LLC. All rights reserved.
Last Updated: June 24, 2003 |